Status:
COMPLETED
Advance Provision of Postpartum Emergency Contraception and Its Effects on Reproductive Autonomy
Lead Sponsor:
Northwestern University
Collaborating Sponsors:
Society of Family Planning
Conditions:
Contraception
Contraceptive Usage
Eligibility:
FEMALE
16-40 years
Brief Summary
This study will entail provision of ulipristal acetate (UPA) for emergency contraception (EC) in the postpartum period for patients who have not chosen to initiate a highly effective form of contracep...
Detailed Description
This project will be a prospective observational study, using a mixed-methods design to further explore the impact of emergency contraception (EC) use on postpartum patients' feelings of reproductive ...
Eligibility Criteria
Inclusion
- 16-40 years of age
- English-speaking
- In a sexual relationship with possibility of pregnancy
- Delivered a live infant
- Desire to delay pregnancy for at least a year
- A patient at Northwestern University Feinberg School of Medicine Department of Obstetrics and Gynecology
- Choosing no postpartum contraceptive method or a lower efficacy method: condoms, female condoms, diaphragm/cervical cap/sponge, fertility awareness method
Exclusion
- Allergy to UPA
- Those who have had tubal sterilization
- Those who conceived via assisted reproductive technology
- Those with inability to follow up
- Those taking drugs that interact with UPA (CYP3A4 inducers, abametapir, felbamate, fexinidazole, fusidic acid, griseofulvin, oxcarbazepine, progestins, topiramate)
Key Trial Info
Start Date :
March 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 22 2024
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT05285605
Start Date
March 1 2022
End Date
January 22 2024
Last Update
April 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern Medicine Prentice Women's Hospital
Chicago, Illinois, United States, 60611